Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Volavka, J.
1995.
Lead-in placebo washout period.
British Journal of Psychiatry,
Vol. 167,
Issue. 5,
p.
694.
Fujian Song
1997.
Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials.
Journal of Psychopharmacology,
Vol. 11,
Issue. 1,
p.
65.
Zito, Julie Magno
1998.
PHARMACOECONOMICS OF THE NEW ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA.
Psychiatric Clinics of North America,
Vol. 21,
Issue. 1,
p.
181.
King, DJ
1998.
Quetiapine: results of four phase II and III clinical trials.
European Psychiatry,
Vol. 13,
Issue. ,
p.
15s.
King, David J
1998.
Drug treatment of the negative symptoms of schizophrenia.
European Neuropsychopharmacology,
Vol. 8,
Issue. 1,
p.
33.
Binder, Renée L.
McNiel, Dale E.
and
Sandberg, David A.
1998.
A Naturalistic Study of Clinical Use of Risperidone.
Psychiatric Services,
Vol. 49,
Issue. 4,
p.
524.
King, DJ
1998.
Quetiapine: Results of four phase II and III clinical trials.
European Psychiatry,
Vol. 13,
Issue. S1,
p.
15s.
Azorin, Jean-Michel
Spiegel, René
Remington, Gary
Vanelle, Jean-Marie
Péré, Jean-Jacques
Giguere, Monique
and
Bourdeix, Isabelle
2001.
A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia.
American Journal of Psychiatry,
Vol. 158,
Issue. 8,
p.
1305.
Kulhanek, F.
2002.
Fortschritte in Psychiatrie und Psychotherapie.
p.
51.
eLetters
No eLetters have been published for this article.